(A) Survival of ovarian cancer patients (pooled stages II, III, and IV) stratified by high (above median) or low (below median) number of IL-17–expressing cells in tumor-infiltrating T cells. (B) Coexpression of multiple proinflammatory cytokines by IL-17–expressing cells in the tumor-infiltrating T-cell population. See the complete figure in the article beginning on page 1141.